Search research articles
Contact Us
Filters
Showing results (21-30 of 91) with videos related to
Page
of 10
Sort By:
The Biochemical Journal
|
July 14, 2007
The terminal step in vitamin C biosynthesis in Trypanosoma cruzi is mediated by a FMN-dependent galactonolactone oxidase
Flora J Logan, Martin C Taylor, Shane R Wilkinson, et al.
BMC Genomics
|
January 20, 2012
Centromere-associated repeat arrays on Trypanosoma brucei chromosomes are much more extensive than predicted
Maria C Echeverry, Christopher Bot, Samson O Obado, et al.
Cellular Microbiology
|
February 27, 2016
Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy
Michael D Lewis, Amanda Fortes Francisco, Martin C Taylor, et al.
Parasitology
|
August 24, 2017
Biological factors that impinge on Chagas disease drug development
Amanda F Francisco, Shiromani Jayawardhana, Michael D Lewis, et al.
Future Medicinal Chemistry
|
June 5, 2019
Novel 2,6-diketopiperazine-derived acetohydroxamic acids as promising anti-<i>Trypanosoma brucei</i> agents
George Fytas, Grigoris Zoidis, Martin C Taylor, et al.
Genome Research
|
January 6, 2005
Functional mapping of a trypanosome centromere by chromosome fragmentation identifies a 16-kb GC-rich transcriptional "strand-switch" domain as a major feature
Samson O Obado, Martin C Taylor, Shane R Wilkinson, et al.
Plos Neglected Tropical Diseases
|
April 16, 2015
The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence
Martin C Taylor, Michael D Lewis, Amanda Fortes Francisco, et al.
Antimicrobial Agents and Chemotherapy
|
November 19, 2015
Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs"
Amanda Fortes Francisco, Michael D Lewis, Shiromani Jayawardhana, et al.
RSC Medicinal Chemistry
|
January 22, 2021
Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against <i>T. brucei</i>
Markos-Orestis Georgiadis, Violeta Kourbeli, Ioannis P Papanastasiou, et al.
ACS Medicinal Chemistry Letters
|
July 17, 2024
New Lipophilic Hydroxamates as Promising Trypanocidal Agents: Design, Synthesis, SAR, and Conformational Behavior Studies
George Fytas, Grigoris Zoidis, Antonios Drakopoulos, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 91) with videos related to
Sort By:
Page
of 10
The Biochemical Journal
|
July 14, 2007
The terminal step in vitamin C biosynthesis in Trypanosoma cruzi is mediated by a FMN-dependent galactonolactone oxidase
Flora J Logan, Martin C Taylor, Shane R Wilkinson, et al.
BMC Genomics
|
January 20, 2012
Centromere-associated repeat arrays on Trypanosoma brucei chromosomes are much more extensive than predicted
Maria C Echeverry, Christopher Bot, Samson O Obado, et al.
Cellular Microbiology
|
February 27, 2016
Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy
Michael D Lewis, Amanda Fortes Francisco, Martin C Taylor, et al.
Parasitology
|
August 24, 2017
Biological factors that impinge on Chagas disease drug development
Amanda F Francisco, Shiromani Jayawardhana, Michael D Lewis, et al.
Future Medicinal Chemistry
|
June 5, 2019
Novel 2,6-diketopiperazine-derived acetohydroxamic acids as promising anti-<i>Trypanosoma brucei</i> agents
George Fytas, Grigoris Zoidis, Martin C Taylor, et al.
Genome Research
|
January 6, 2005
Functional mapping of a trypanosome centromere by chromosome fragmentation identifies a 16-kb GC-rich transcriptional "strand-switch" domain as a major feature
Samson O Obado, Martin C Taylor, Shane R Wilkinson, et al.
Plos Neglected Tropical Diseases
|
April 16, 2015
The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence
Martin C Taylor, Michael D Lewis, Amanda Fortes Francisco, et al.
Antimicrobial Agents and Chemotherapy
|
November 19, 2015
Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs"
Amanda Fortes Francisco, Michael D Lewis, Shiromani Jayawardhana, et al.
RSC Medicinal Chemistry
|
January 22, 2021
Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against <i>T. brucei</i>
Markos-Orestis Georgiadis, Violeta Kourbeli, Ioannis P Papanastasiou, et al.
ACS Medicinal Chemistry Letters
|
July 17, 2024
New Lipophilic Hydroxamates as Promising Trypanocidal Agents: Design, Synthesis, SAR, and Conformational Behavior Studies
George Fytas, Grigoris Zoidis, Antonios Drakopoulos, et al.
Page
of 10